News 2 Nov 2026 Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
Press releases 29 Oct 2026 DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai
Scientific articles 27 Oct 2026 Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022) Frontiers in Tropical Diseases
Scientific articles 26 Oct 2026 Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial eClinicalMedicine
Scientific articles 22 Oct 2026 Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis Nature communications
Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infectious Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 1 Jun 2023 Statement from Dr Luis Pizarro, Executive Director of DNDi, about the Princess of Asturias Award for International Cooperation
News 3 Mar 2023 Working together to ensure optimal treatment for children living with HIV in South Africa
News 20 Feb 2023 First in-person Dengue Alliance meeting brings together experts from dengue-endemic countries to develop treatments for a growing viral threat
News 30 Jan 2023 It’s time medical innovation reached the 1.7 billion people affected by neglected tropical diseases: World NTD Day 2023
News 23 Nov 2022 DNDi media workshops – bringing together reporters and researchers to cover neglected disease research
News 21 Nov 2022 Reporting on climate change and neglected diseases: DNDi at the World Conference of Francophone Science Journalists
News 16 Nov 2022 DNDi Asia media workshop – Science journalism in an age of climate-sensitive diseases
News 25 Oct 2022 Tusen takk! MSF-Norway and DNDi gather a record NOK 266 million during the televised Norwegian solidarity campaign TV-Aksjonen
News 3 Oct 2022 DNDi 2022 Projects of the Year recognize partners and colleagues for their work in developing new treatments for leishmaniasis
News 23 Sep 2022 In every home and heart in Norway: DNDi and MSF beneficiaries of the 2022 edition of TV-Aksjonen, the largest Norwegian charity event
